Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Ephedrine and unheralded sudden cardiac death

15.10.2004


New study links possible role of ephedrine in the sudden cardiac death of people with asymptomatic heart disease



Each year 80 to 100,000 Americans die suddenly from heart attacks without ever having had any symptoms of heart disease. In some cases, the victims of these unheralded sudden cardiac deaths had been taking dietary supplements containing ephedrine. In a new study in the Oct. 26, 2004 issue of the Journal of the American College of Cardiology, researchers show how ephedrine can cause sudden cardiac death in an animal model of asymptomatic heart disease.

"For our experiment, we went to the local health food store, bought ephedrine supplements and gave our animals the dose recommended on the label," said Philip B. Adamson, M.D., associate professor in the department of physiology and the department of medicine - cardiovascular diseases at the University of Oklahoma Health Sciences Center in Oklahoma City, Okla. and lead author of the study. "Ephedrine mimics the sympathetic nervous system, the part of the nervous system that makes the heart beat stronger and faster. In past experiments on obese, otherwise healthy individuals ephedrine did not raise their heart rates when they were either at rest or exercising." Dr. Adamson spoke today at the American Medical Association’s 23rd Annual Science Reporters Conference in Washington D.C.


"When we gave healthy animals ephedrine, we found exactly the same thing," Dr. Adamson said. "But the moment they developed a blockage in their heart artery, which we are able to cause reversibly, their heart rates went through the roof. It was the response to ischemia, a condition where there is a blockage of the heart’s blood supply that was exaggerated by ephedrine."

"In ischemic heart disease, the blood supply to the heart becomes constricted, causing damage to the heart muscle and heart disease. However, sometimes the condition develops without any symptoms, leading to a sudden heart attack. Death can be the first symptom people with ischemic heart disease experience," Dr. Adamson said. "We wanted to determine how ephedrine, taken as directed, might cause someone with ischemic heart disease to have a potentially fatal heart attack." "Ephedrine looks benign when you look at its effects on normal heart rates, but when there is a blockage, boom, ephedrine causes a potentially lethal arrhythmia," Dr. Adamson said. "The heart starts beating so fast, it can no longer pump blood."

Dr. Adamson used an animal model of ischemic heart disease. Of the 15 animals given ephedrine, nine had increased ventricular arrhythmias (a dangerous and wild beating of the heart) and four had ventricular fibrillation (VF, an extreme arrhythmia where the heart can no longer pump). One of the four animals with VF could not be resuscitated.

Ephedrine was marketed for many years as an aid to weight loss and an enhancer of athletic performance, but has never been systematically studied, although it has been implicated in hundreds of adverse reactions. "As the cardiologist for the university’s athletic department, I was interested in researching ephedrine’s effects on the body," Dr. Adamson said. "I was amazed at the number of student athletes taking ephedrine and other supplements without really any idea what they did."

"We have been studying how the sympathetic nervous system destabilizes the heart’s electrical system and increases the risk of arrhythmia for some time. We didn’t expect such a dramatic response to ephedrine," he said. "The sympathetic nervous system was super-powered by the ephedrine, greatly increasing the risk of causing an instability of the electro-physiology of the heart."

"This study certainly supports the FDA’s decision to ban ephedrine from dietary supplements (the ban went into effect in February 2004)," Dr. Adamson said. "I hope it will also offer us additional insights into the nature and causes of unheralded sudden death."

Christine M. Feheley | EurekAlert!
Further information:
http://www.acc.org

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>